Press release
Epigenetics Market Revenue and Value Chain 2018-2027
Epigenetics Research Funding to Radiate a Cohort of Opportunities for Chronic Disease TreatmentsIncreasing funding for research and development for discovering therapeutic solutions continues to remain instrumental in product development pertaining to epigenetics space. With growing concerns regarding prevalence of chronic diseases such as cancer, diabetes and other metabolic diseases, organizations such as the National Institute of Health (NIH), National Cancer Institute (NCI) and the International Human Epigenome Consortium (IHEC) have encouraged advanced research in epigenetics field by undertaking new research initiatives such as the Epidemiology and Genomics Research Program. This factor has largely facilitated the novel therapeutic products, in turn supporting the epigenetics market.
Request Brochure of this Report@ https://www.factmr.com/connectus/sample?flag=B&rep_id=435
Epigenetics Gaining Ground in Cancer Therapeutics
Pervasiveness of epigenetics in biology has facilitated study of various alterations in gene expression that has played a vital role in understanding development of cancer cells and developing appropriate medications. Increasing prevalence of cancer cases worldwide have fuelled the need for advanced therapeutics to treat the chronic disease, which has influenced the growth of epigenetics market. For instance, World Health Organization (WHO) estimates that the cancer mortality rate in India has surpassed 79 per 100,000 deaths in the coming years. Likewise, American Cancer Society reveals that in 2017, United States reflected about 1,688,780 cancer cases and this figure is likely to increase in the future owing to improper lifestyle and high percentage of smoking and drinking. That said, the demand for cancer treatment and novel therapeutics has evolved to the next level using epigenetic research, which is likely to support the epigenetics market growth in the coming years.
Increasing Cardiovascular Diseases to Spearhead Epigenetics Demand
Prevalence of cardiovascular diseases (CVDs) was high in the past and is expected to further grow in the coming years owing to improper lifestyle and eating patterns. For instance, according to European Cardiovascular Disease Statistics, in 2017, cardiovascular diseases accounted for around 45 percent of deaths in the European countries. Japan is no exception to this, as deaths owing to heart related disorders have risen in the country, making it a subject of concern and high importance for medical practitioners there. Cardiovascular diseases have become pandemic with unhealthy lifestyle and excess consumption of food. Pervasiveness of this metabolic syndrome can be well addressed using novel therapies with epigenetics as their base. That said, increasing funding for research on therapies based on epigenetics for treating CVDs is expected to push the growth of the epigenetics market in the years to follow.
Get Free Exclusive Sample Copy of This Report @
https://www.factmr.com/connectus/sample?flag=S&rep_id=435
Epigenetics Facilitating New Generation of Diagnostics
Modifications in epigenetics are stable and offer strong signals acting as biomarkers for diseases that can be measured and mapped using HMCP platforms. Epigenetics biomarkers are largely specific for tissue type and disease state. According to scientific researchers, epigenetics can provide platforms for early detection of diseases as they can precede alterations in genetics. Minimally invasive techniques in combination with epigenetics platforms can provide informative tools that can facilitate swift and accurate diagnosis of diseases. With epigenetics as a novel diagnostic platform, a radical approach toward wellbeing management and long-term health can be envisaged allowing implementation of tailored clinical interventions, making diseases not inevitable, but optional.
Errors Causing Misleading Results in DNA-seq – A Critical Challenge
Albeit its high potential in diagnosis and development of novel therapeutics, epigenetics are associated with errors, especially with respect to the DIP-seq, a widely used method. Different cells in human body use different gene groups. This necessitates the use of additional signals in order to control the respective gene type used for that particular cell. DNA-seq, being attached to chemical groups processing such signals, is likely to make error in the epigenetic code, which can lead to misleading results. This aspect is likely to challenge the epigenetics market.
Report Analysis at https://www.factmr.com/report/435/epigenetics-market
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epigenetics Market Revenue and Value Chain 2018-2027 here
News-ID: 1450911 • Views: …
More Releases from Fact.MR

Global Data Catalog Market to Explode to $12.3 Billion by 2035, Driven by AI and …
The global Data Catalog Market is undergoing a rapid, technology-driven transformation, shifting its role from a passive metadata repository to an intelligent, active data intelligence platform. Propelled by the exponential growth in complex data and regulatory demands, the market is projected to reach an estimated US$12.32 Billion by 2035, according to leading market analysis.
This dramatic surge represents a Compound Annual Growth Rate (CAGR) of 21.9% throughout the forecast period of…

Content Delivery Network (CDN) Market to Reach USD 45.2 Billion by 2035 | Akamai …
The latest report on the Content Delivery Network (CDN) Market, forecasting robust growth propelled by surging global data traffic, the proliferation of streaming services, and the escalating demand for low-latency digital experiences. Valued at USD 18.5 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 9.4%, reaching USD 45.2 billion by 2035. This trajectory reflects the indispensable role of CDNs in…

Energy-based Aesthetic Devices Market Grow at a 10.8% CAGR by 2035 | Key Players …
latest report on the Energy-based Aesthetic Devices Market, forecasting robust growth propelled by surging demand for non-invasive dermatological treatments, technological innovations in laser, radiofrequency, ultrasound, and light-based systems, and heightened beauty awareness among consumers. Valued at USD 5,476.2 million in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 10.8%, reaching USD 15,180.4 million by 2035. This trajectory reflects the market's pivotal role…

Global Surgical Tourniquets Market Projected to Nearly Triple, Reaching US$1.59 …
The global surgical tourniquets market is poised for significant expansion over the next decade, driven by a global surge in orthopedic surgeries, heightened demand for safer intraoperative blood control, and major technological advancements in pressure regulation systems. According to a comprehensive analysis by Fact.MR, the market, valued at US 670 millionin 2025,is forecasted to grow at a steady Compound Annual Growth Rate(CAGR) of 91.59 billion. This robust growth trajectory is…
More Releases for Epigenetics
Epigenetics Services Analysis Report : the global Epigenetics Services market si …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Epigenetics Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global…
Epigenetics: Critical Driver Shaping the Rising Cancer Prevalence And Other Dise …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Epigenetics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for epigenetics has seen a significant expansion in the last few years. The market is projected to escalate from $10.65 billion in 2024 to $12.83 billion in 2025, displaying a compound annual growth rate (CAGR) of 20.4%. The…
Epigenetics Market Trends and Research Developments
On March 25, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Epigenetics Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Complete PDF Guide to Epigenetics
A single or multiple changes in phenotype without changing the genotype which affects the cells. The changes occurred due to epigenetics are regular and natural and can also be influenced by several factors such as age, environment, lifestyle, and conditions of diseases.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPHE100000971/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Epigenetics Market are:
• Merck KgaA
• Thermo Fisher Scientific Inc
• Abcam Plc
• Agilent Technologies Inc
• Qiagen
• Bio-Rad Laboratories Inc
• Active Motif
• Perkin Elmer Inc
• New…
Epigenetics Market worth $4.3 billion by 2028
Browse 367 market data Tables and 45 Figures spread through 366 Pages and in-depth TOC on "Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology) - Global Forecast to 2028
Epigenetics Market [https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html?utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $1.8 billion in 2023 and is poised to reach $4.3 billion by…
Epigenetics Analysis: The Roadmap to Precision Oncology
[City, Date] - In the dynamic landscape of modern medicine, precision oncology has emerged as a transformative force, leveraging genomic data to provide patient-specific cancer treatments. This groundbreaking field, now seamlessly integrated into mainstream clinical practices, relies on epigenetic analysis to unravel the molecular intricacies of cancer cells and identify targetable alterations, commonly known as biomarkers.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5628
Epigenetic analysis, enabling the rapid and reliable sequencing of multiple…